{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:34:22Z","timestamp":1793093662449,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"am","delay-in-days":306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1012316-CHE"],"award-info":[{"award-number":["1012316-CHE"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bbagen.2017.01.029","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T02:31:53Z","timestamp":1485484313000},"page":"848-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate"],"prefix":"10.1016","volume":"1861","author":[{"given":"Mohamed F.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brezden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2017.01.029_bb0005","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/605539","article-title":"Bad bugs, no drugs: no ESCAPE revisited","volume":"49","author":"Peterson","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0010","author":"CDC"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0025","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1128\/AAC.03926-14","article-title":"Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in Colombia","volume":"59","author":"Correa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1469-0691.2005.01305.x","article-title":"Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes","volume":"12","author":"Wang","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0035","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1128\/JB.01651-09","article-title":"Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis","volume":"192","author":"Mulcahy","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"Hoiby","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11373-007-9194-y","article-title":"Aminoglycosides versus bacteria\u2014a description of the action, resistance mechanism, and nosocomial battleground","volume":"15","author":"Shakil","year":"2008","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: activity and resistance","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.16.3.430-450.2003","article-title":"Versatility of aminoglycosides and prospects for their future","volume":"16","author":"Vakulenko","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0065","doi-asserted-by":"crossref","first-page":"9664","DOI":"10.1002\/anie.201302693","article-title":"Targeting intracellular pathogenic bacteria with unnatural proline-rich peptides: coupling antibacterial activity with macrophage penetration","volume":"52","author":"Kuriakose","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0070","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.6b04831","article-title":"Dual targeting of intracellular pathogenic bacteria with a cleavable conjugate of kanamycin and an antibacterial cell-penetrating peptide","author":"Brezden","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0075","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow aerobically; Approved Standard M7-A7","author":"CLSI","year":"2007"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.01619-12","article-title":"Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin","volume":"57","author":"Yan","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0085","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/AAC.00918-12","article-title":"Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments","volume":"56","author":"Nagant","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0090","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1128\/AAC.02578-14","article-title":"Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides","volume":"58","author":"Mohamed","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0095","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/AAC.49.8.3114-3121.2005","article-title":"Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus","volume":"49","author":"Xiong","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116259","article-title":"Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs","volume":"9","author":"Mohamed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0105","doi-asserted-by":"crossref","DOI":"10.3791\/2437","article-title":"Microtiter dish biofilm formation assay","author":"O'Toole","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0110","doi-asserted-by":"crossref","first-page":"29707","DOI":"10.1038\/srep29707","article-title":"Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus","volume":"6","author":"Mohamed","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0115","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1128\/AAC.00169-13","article-title":"Introduction of a lysine residue promotes aggregation of temporin L in lipopolysaccharides and augmentation of its antiendotoxin property","volume":"57","author":"Srivastava","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0120","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2147\/DDDT.S72129","article-title":"Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection","volume":"8","author":"Mohamed","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0125","doi-asserted-by":"crossref","first-page":"11596","DOI":"10.1038\/srep11596","article-title":"Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections","volume":"5","author":"Thangamani","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0130","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1073\/pnas.0604055103","article-title":"Identification of novel antimicrobials using a live-animal infection model","volume":"103","author":"Moy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2008","key":"10.1016\/j.bbagen.2017.01.029_bb0135","article-title":"A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds","volume":"3","author":"Tampakakis","year":"1925","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/AAC.05829-11","article-title":"PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients","volume":"56","author":"Moskowitz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0145","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0150","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","author":"Liu","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0155","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1128\/IAI.69.8.4916-4922.2001","article-title":"Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides","volume":"69","author":"Koo","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11908-004-0042-1","article-title":"The advantage of bactericidal drugs in the treatment of infection","volume":"6","author":"Alder","year":"2004","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0170","first-page":"235","article-title":"Staphylococcus aureus persisters tolerant to bactericidal antibiotics","volume":"22","author":"Lechner","year":"2012","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-1097(03)00856-5","article-title":"Persister cells and tolerance to antimicrobials","volume":"230","author":"Keren","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2474","article-title":"Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections","volume":"9","author":"Hurdle","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0185","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/AAC.02218-12","article-title":"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens","volume":"57","author":"Deslouches","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0190","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.biomaterials.2013.10.053","article-title":"Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic beta-sheet forming peptide amphiphiles","volume":"35","author":"Ong","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0195","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"Hoiby","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-96-1-1","article-title":"Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis","volume":"96","author":"Christensen","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0215","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/AAC.48.7.2633-2636.2004","article-title":"Enzymatic detachment of Staphylococcus epidermidis biofilms","volume":"48","author":"Kaplan","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0220","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/jac\/dkq257","article-title":"Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms","volume":"65","author":"Singh","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S143192760999136X","article-title":"Observing the biofilm matrix of Staphylococcus epidermidis ATCC 35984 grown using the CDC biofilm reactor","volume":"16","author":"Williams","year":"2010","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00289-15","article-title":"Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes","volume":"6","author":"Soong","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0240","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/320519","article-title":"Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease","volume":"32","author":"von Eiff","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0882-4010(03)00112-8","article-title":"In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins","volume":"35","author":"Brouillette","year":"2003","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0250","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.02609-12","article-title":"Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes","volume":"57","author":"Buyck","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0255","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1365-2133.2002.04752.x","article-title":"Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death","volume":"146","author":"Mempel","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/nyas.12444","article-title":"Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies","volume":"1323","author":"Lyle","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0265","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2017.01.029_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0275","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0280","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/AAC.00154-10","article-title":"Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo","volume":"54","author":"Uccelletti","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0285","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.04198-14","article-title":"Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model","volume":"59","author":"Jayamani","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","article-title":"D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections","volume":"22","author":"de la Fuente-Nunez","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030057","article-title":"Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses","volume":"3","author":"Begun","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0300","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/IAI.73.2.872-877.2005","article-title":"Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model","volume":"73","author":"Begun","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1574-695X.2012.00975.x","article-title":"Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections","volume":"65","author":"Edwards","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.bbagen.2017.01.029_bb0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/mp800174g","article-title":"Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin","volume":"6","author":"Patel","year":"2009","journal-title":"Mol. Pharm."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416517300375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416517300375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:53:54Z","timestamp":1759636434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416517300375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0304416517300375"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.01.029","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}